Page last updated: 2024-12-11

1-benzyl-5-(2,6-dimethyl-1,5-heptadienyl)imidazole

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

1-benzyl-5-(2,6-dimethyl-1,5-heptadienyl)imidazole, also known as **Imidazole 1** or **IMI-1**, is a synthetic organic compound that has shown promising activity in various research areas.

**Structure:**

IMI-1 is an imidazole derivative with a benzyl group at the 1-position and a 2,6-dimethyl-1,5-heptadienyl substituent at the 5-position.

**Why it is important for research:**

IMI-1 has garnered interest in several research fields due to its potential applications, including:

* **Antimicrobial activity:** IMI-1 exhibits significant antimicrobial activity against a broad spectrum of bacteria, including multi-drug resistant strains. This property makes it a potential candidate for the development of new antibiotics.
* **Antiparasitic activity:** Research suggests that IMI-1 possesses antiparasitic activity against certain parasites, including Leishmania and Trypanosoma. This opens up possibilities for developing treatments for parasitic diseases.
* **Anti-inflammatory activity:** IMI-1 has demonstrated anti-inflammatory properties in studies. This suggests its potential use in managing inflammatory conditions.
* **Cancer research:** Preliminary investigations indicate that IMI-1 may possess anticancer activity by interfering with cancer cell growth and proliferation. Further studies are needed to confirm its efficacy in this area.

**Mechanism of action:**

The exact mechanism of action of IMI-1 is not fully understood. However, it is believed that the compound interacts with various cellular targets, including:

* **Bacterial membranes:** IMI-1 disrupts bacterial cell membranes, leading to cell death.
* **Enzymes:** IMI-1 may inhibit the activity of certain enzymes essential for the survival of bacteria and parasites.
* **Signaling pathways:** IMI-1 could interfere with signaling pathways involved in inflammation and cancer cell growth.

**Current research:**

Ongoing research focuses on:

* **Optimizing IMI-1's efficacy:** Researchers are exploring modifications to the structure of IMI-1 to enhance its activity and bioavailability.
* **Identifying its specific targets:** Studies aim to elucidate the exact molecular targets responsible for IMI-1's diverse biological effects.
* **Developing new therapeutic agents:** The promising properties of IMI-1 are driving the development of new drugs based on this compound for treating infections, inflammation, and cancer.

**Overall:**

1-benzyl-5-(2,6-dimethyl-1,5-heptadienyl)imidazole is a versatile compound with significant potential in various research areas. Its antimicrobial, antiparasitic, anti-inflammatory, and potential anticancer activities make it a promising lead compound for the development of new therapies. However, further research is necessary to fully understand its mechanism of action and to develop safe and effective drugs based on this molecule.

1-benzyl-5-(2,6-dimethyl-1,5-heptadienyl)imidazole: affects oocyte & egg development in Locusta migratoria; RN given refers to (E)-isomer [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID6437853
CHEMBL ID2287148
SCHEMBL ID9647782
MeSH IDM0175659

Synonyms (11)

Synonym
1-benzyl-5-[(1e)-2,6-dimethylhepta-1,5-dienyl]imidazole
kk-42
1h-imidazole, 5-(2,6-dimethyl-1,5-heptadienyl)-1-(phenylmethyl)-, (e)-
1-benzyl-5-(2,6-dimethyl-1,5-heptadienyl)imidazole
5-((1e)-2,6-dimethyl-1,5-heptadienyl)-1-(phenylmethyl)-1h-imidazole
96108-89-3
CHEMBL2287148
(e)-1-benzyl-5-(2,6-dimethylhepta-1,5-dien-1-yl)-1h-imidazole
1-benzyl-5-[(e)-2,6-dimethyl-1,5-heptadienyl]imidazole
JLGZMQRNESBDEI-SFQUDFHCSA-N
SCHEMBL9647782
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (10)

TimeframeStudies, This Drug (%)All Drugs %
pre-19901 (10.00)18.7374
1990's0 (0.00)18.2507
2000's6 (60.00)29.6817
2010's3 (30.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 11.76

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index11.76 (24.57)
Research Supply Index2.40 (2.92)
Research Growth Index4.16 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (11.76)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other10 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]